These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30704971)

  • 1. I
    Nascimento AR; Gomes F; Machado MV; Gonçalves-de-Albuquerque C; Bousquet P; Tibiriçá E
    Auton Neurosci; 2019 Mar; 217():18-25. PubMed ID: 30704971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral Microvascular Dysfunction and Inflammation Are Improved by Centrally Acting Antihypertensive Drugs in Metabolic Syndrome.
    Estato V; Nascimento A; Antunes B; Gomes F; Coelho L; Rangel R; Garzoni L; Daliry A; Bousquet P; Tibiriçá E
    Metab Syndr Relat Disord; 2017 Feb; 15(1):26-35. PubMed ID: 27929741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Sympathetic Modulation Reverses Microvascular Alterations in a Rat Model of High-Fat Diet-Induced Metabolic Syndrome.
    Nascimento AR; Machado MV; Gomes F; Vieira AB; Gonçalves-de-Albuquerque CF; Lessa MA; Bousquet P; Tibiriçá E
    Microcirculation; 2016 May; 23(4):320-9. PubMed ID: 27086551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats.
    Fellmann L; Regnault V; Greney H; Gasparik V; Muscat A; Max JP; Gigou L; Oréa V; Chetrite G; Pizard A; Niederhoffer N; Julien C; Lacolley P; Fève B; Bousquet P
    J Pharmacol Exp Ther; 2013 Sep; 346(3):370-80. PubMed ID: 23818682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise training dose differentially alters muscle and heart capillary density and metabolic functions in an obese rat with metabolic syndrome.
    Machado MV; Vieira AB; da Conceição FG; Nascimento AR; da Nóbrega ACL; Tibirica E
    Exp Physiol; 2017 Dec; 102(12):1716-1728. PubMed ID: 28921743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness of α2-adrenoceptor/I1-imidazoline receptor in the rostral ventrolateral medulla to cardiovascular regulation is enhanced in conscious spontaneously hypertensive rat.
    Yamazato M; Nakamoto M; Sakima A; Yamazato Y; Takishita S; Ohya Y
    Clin Exp Hypertens; 2019; 41(3):255-262. PubMed ID: 29764227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional microvascular alterations in a rat model of metabolic syndrome induced by a high-fat diet.
    Nascimento AR; Machado M; de Jesus N; Gomes F; Lessa MA; Bonomo IT; Tibiriçá E
    Obesity (Silver Spring); 2013 Oct; 21(10):2046-54. PubMed ID: 23512529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P; Friedman JE; Koletsky RJ
    J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D; Haxhiu MA; Kaan EC; Papp JG; Ernsberger P
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.
    Gasparik V; Greney H; Schann S; Feldman J; Fellmann L; Ehrhardt JD; Bousquet P
    J Med Chem; 2015 Jan; 58(2):878-87. PubMed ID: 25521963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats.
    Estato V; Araújo CV; Bousquet P; Tibiriçá E
    Braz J Med Biol Res; 2004 Oct; 37(10):1541-9. PubMed ID: 15448876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist.
    Turcani M
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):524-35. PubMed ID: 19034032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
    Koletsky RJ; Velliquette RA; Ernsberger P
    Ann N Y Acad Sci; 2003 Dec; 1009():251-61. PubMed ID: 15028595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of non-quinazoline α
    Kubacka M; Kotańska M; Szafarz M; Pociecha K; Waszkielewicz AM; Marona H; Filipek B; Mogilski S
    Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):751-760. PubMed ID: 31133498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives.
    Wenzel RR; Spieker L; Qui S; Shaw S; Lüscher TF; Noll G
    Hypertension; 1998 Dec; 32(6):1022-7. PubMed ID: 9856967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.